Midi Health Raises Additional $60M in Series B Funding

Midi Health
Midi Health Founders, From left: CEO Joanna Strober, COO Sharon Meers, Chief Medical Officer Kathleen Jordan, MD, Chief Brand Officer Jill Herzig

Midi Health, a Los Altos, CA-based virtual care clinic for women navigating perimenopause and menopause, raised additional $60M in Series B funding.

The round, which brought the total amount to $100M, was led by Emerson Collective, with participation from GV (Google Ventures), who led the previous funding round, along with Memorial Hermann, SemperVirens, Felicis, Icon Ventures, Black Angel Group, Gingerbread Capital, Able Partners, G9 and Operator Collective. They joined a syndicate of primarily female-led investors including F7, Steel Sky Ventures, Avestria, Muse Capital, 1843 Capital, Anne Wojcicki, Susan Wojcicki, and K50 Ventures.

The company intends to use the funds to expand insurance coverage (already established nationwide), hire and upskill an additional 150 clinicians by end of year, diversify service lines, amplify the conversation around midlife women’s healthcare, and scale to care for 1 million+ women per year by 2029.

Led by CEO Joanna Strober, COO Sharon Meers, CMO Kathleen Jordan, MD, CBO Jill Herzig, Midi Health is a virtual care clinic focused on women navigating midlife hormonal change and beyond. With treatment protocols created by medical experts in perimenopause and menopause, delivered by clinicians trained in women’s midlife health, it provides patients with personalized care plans that include hormonal and non-hormonal medications, supplements, lifestyle coaching and more. All services are covered by insurance, and conveniently accessible through telehealth visits and 24/7 messaging.

Commenting on the news, Joanna Strober said: “We started Midi with just one specific focus: helping women access world-class, expert perimenopause and menopause care, covered by insurance, and we have been at the forefront of delivering on that promise.